A deep team and proven approach make Hartford Healthcare a worthwhile offering.
Hartford Healthcare C HGHCX
- NAV / 1-Day Return 26.62 / +0.26 %
- Total Assets 1.2 Bil
-
Adj. Expense Ratio
- Expense Ratio 2.050%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield —
- Turnover 32%
USD | NAV as of Mar 18, 2024 | 1-Day Return as of Mar 18, 2024, 10:18 PM GMT+0
Morningstar’s Analysis HGHCX
Will HGHCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 9.75 | 111.9 Mil | Healthcare |
UnitedHealth Group Inc | 7.35 | 84.4 Mil | Healthcare |
Merck & Co Inc | 6.30 | 72.3 Mil | Healthcare |
Danaher Corp | 3.87 | 44.4 Mil | Healthcare |
Stryker Corp | 2.85 | 32.6 Mil | Healthcare |
Boston Scientific Corp | 2.80 | 32.1 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 2.66 | 30.5 Mil | Healthcare |
HCA Healthcare Inc | 2.59 | 29.7 Mil | Healthcare |
Thermo Fisher Scientific Inc | 2.49 | 28.6 Mil | Healthcare |
Centene Corp | 2.29 | 26.3 Mil | Healthcare |